The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
- 1 June 1999
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 74 (6), 613-634
- https://doi.org/10.4065/74.6.613
Abstract
No abstract availableKeywords
This publication has 267 references indexed in Scilit:
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992–1994: The Alexander ProjectDiagnostic Microbiology and Infectious Disease, 1996
- Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virusThe Journal of Pediatrics, 1996
- In vitro activity of macrolides against intracellular Legionella pneumophilaDiagnostic Microbiology and Infectious Disease, 1996
- Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndromeThe Journal of Pediatrics, 1994
- Drug intolerance to high-dose clarithromycin among elderly patientsDiagnostic Microbiology and Infectious Disease, 1993
- Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological, and clinical overviewDiagnostic Microbiology and Infectious Disease, 1992
- Drug‐Food Interaction Potential of Clarithromycin, A New Macrolide AntimicrobialThe Journal of Clinical Pharmacology, 1992
- Mycobacterium aviumComplex and the Normal HostsNew England Journal of Medicine, 1989
- Bioinequivalence of Erythromycin Ethylsuccinate and Enteric-Coated Erythromycin Pellets Following Multiple Oral DosesThe Journal of Clinical Pharmacology, 1985